Federation Des Caisses Desjardins Du Quebec Oncolytics Biotech Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$23.7 Billion
Q3 2025

A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 31,899 shares of ONCY stock, worth $33,493. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,899

Previous 35,794 10.88%

Holding current value

$33,493

Previous $27,000 62.96%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.75 - $1.43 $2,921 - $5,569	-3,895 Reduced 10.88%	31,899 $44,000
Q2 2025 Aug 14, 2025	BUY	$0.33 - $0.77 $6,600 - $15,400	20,000 Added 126.63%	35,794 $27,000
Q1 2025 May 15, 2025	SELL	$0.55 - $0.93 $1 - $1	-2 Reduced 0.01%	15,794 $8,000
Q3 2024 Nov 13, 2024	BUY	$0.87 - $1.08 $2,176 - $2,702	2,502 Added 18.82%	15,796 $13,000
Q2 2024 Aug 14, 2024	BUY	$0.99 - $1.24 $9,900 - $12,400	10,000 Added 303.58%	13,294 $13,000

Q1 2024 May 15, 2024	BUY	$0.89 - $1.36 $2,931 - $4,479	3,294 New	3,294 $4.68 Million
Q4 2023 Aug 14, 2024	SELL	$1.22 - $2.09 $897 - $1,538	-736 Reduced 18.26%	3,294 $4.36 Million
Q3 2023 Aug 14, 2024	BUY	$1.98 - $3.24 $2,952 - $4,830	1,491 Added 58.72%	4,030 $8.66 Million
Q2 2023 Aug 14, 2024	SELL	$1.11 - $2.74 $2,336 - $5,767	-2,105 Reduced 45.33%	2,539 $6.52 Million
Q1 2023 Aug 14, 2024	SELL	$1.2 - $1.91 $1,515 - $2,412	-1,263 Reduced 21.38%	4,644 $5.56 Million
Q4 2022 Aug 14, 2024	SELL	$1.17 - $2.12 $2,340 - $4,240	-2,000 Reduced 25.29%	5,907 $9.56 Million
Q3 2022 Aug 14, 2024	BUY	$0.98 - $1.51 $3,920 - $6,040	4,000 Added 102.38%	7,907 $9.81 Million
Q2 2022 Aug 14, 2024	BUY	$0.85 - $1.59 $425 - $795	500 Added 14.68%	3,907 $3.76 Million
Q1 2022 Aug 14, 2024	SELL	$1.31 - $2.02 $12,951 - $19,971	-9,887 Reduced 74.37%	3,407 $5.38 Million
Q2 2021 Aug 30, 2024	SELL	$2.6 - $4.64 $25,706 - $45,875	-9,887 Reduced 74.37%	3,407 $9.34 Million
Q1 2021 Aug 30, 2024	SELL	$2.32 - $4.11 $17,898 - $31,708	-7,715 Reduced 47.09%	8,670 $32.5 Million
Q4 2020 Aug 30, 2024	SELL	$1.71 - $4.03 $6,840 - $16,120	-4,000 Reduced 19.62%	16,385 $38.5 Million
Q3 2020 Aug 30, 2024	BUY	$1.58 - $2.15 $5,214 - $7,095	3,300 Added 19.32%	20,385 $34.6 Million
Q2 2020 Aug 30, 2024	BUY	$1.33 - $2.76 $11,970 - $24,839	9,000 Added 111.32%	17,085 $32.2 Million
Q1 2020 Aug 30, 2024	SELL	$0.98 - $4.28 $7,448 - $32,528	-7,600 Reduced 48.45%	8,085 $11.2 Million
Q4 2019 Aug 30, 2024	BUY	$0.42 - $4.76 $3,234 - $36,652	7,700 Added 96.43%	15,685 $74.3 Million
Q4 2018 Aug 30, 2024	SELL	$1.72 - $4.12 $9,131 - $21,873	-5,309 Reduced 39.94%	7,985 $14.3 Million
Q2 2018 Aug 30, 2024	SELL	$4.56 - $7.83 $24,209 - $41,569	-5,309 Reduced 39.94%	7,985 $42.8 Million

Others Institutions Holding ONCY

# of Institutions

Shares Held

2.82M

Call Options Held

Put Options Held

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $60.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account

Federation Des Caisses Desjardins Du Quebec Oncolytics Biotech Inc Transaction History